Cellular delivery of impermeable effector molecules in the form of conjugates with peptides capable of mediating membrane translocation

Bioconjugate Chemistry

Volumn 12, Issue 6, 2001, Pages 825-841

  Fischer, P M ^a   Krausz, E ^a   Lane, D P ^a  

^a CYCLACEL LTD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOLOGY; MACROMOLECULES; MAMMALS; MEMBRANES; OLIGONUCLEOTIDES; VECTORS;

CELL-BE; CELL/B.E; CELL/BE; CELLULAR DELIVERY; DELIVERY VECTOR; LIVING CELL; MEMBRANE TRANSLOCATION; PEPTIDE DELIVERY; PHYSICOCHEMICAL PROPERTY; SMALL MOLECULES;

PEPTIDES;

ANIMALIA; BACTERIA (MICROORGANISMS); INSECTA; MAMMALIA;

EID: 0035210628     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc0155115     Document Type: Review

References (273)

1. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development setting
2. Liposomal drug formulations: Rationale for development and what we can expect for the future
3. Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors
4. Intracellular regulation of macromolecules using pH-sensitive liposomes and nuclear localization signal: Qualitative and quantitative evaluation of intracellular trafficking
5. Intracellular delivery and antibacterial activity of gentamicin encapsulated in pH-sensitive liposomes
6. Lipid-based systems for the intracellular delivery of genetic drugs
7. The role of endosome destabilizing activity in the gene transfer process mediated by cationic lipids
8. Amphiphilic peptide enhance the efficiency of liposome-mediated DNA transfection
9. Influence of membrane-active peptides on lipospermine/DNA complex mediated gene transfer
10. Gene transfer into hepatocytes using asialoglycoprotein receptor mediated endocytosis of DNA complexed with an artificial tetra-antennary galactose ligand
11. Gene delivery: A single nuclear localization signal peptide is sufficient to carry DNA to the cell nucleus
12. Cell-penetrating peptides
13. Evidence for an amphipathicity independent cellular uptake of amphipathic cell-penetrating peptides
14. Bacterial toxins deliver the goods
15. Tetanus toxin fragment forms channels in lipid vesicles at low pH
16. Anthrax toxin-mediated delivery of a cytotoxic T-cell epitope in vivo
17. Structure of a cholesterol-binding, thiol-activated cytolysin and a model of its membrane form
18. Peptides fused to the amino-terminal end of diphtheria toxin are translocated to the cytosol
19. Cytolytic poreforming proteins and peptides: Is there a common structural motif?
20. A molecular model for membrane fusion based on solution studies of an amphiphilic peptide from HIV gp41
21. Identification of a renal cell line that constitutively expresses the kidney-specific high-affinity H+/peptide cotransporter
22. Use of Caco-2 cells and LC/MS/MS to screen a peptide combinatorial library for permeable structures
23. Peptide modulators of protein - Protein interactions in intracellular signaling
24. A novel N-myristylated synthetic octapeptide inhibits protein kinase C activity and partially reverses murine fibrosarcoma cell resistance to adriamycin
25. An improved permeabilization protocol for the introduction of peptides into cardiac mycocytes
26. Liposomal delivery of purified inhibitory-κBα inhibits tumor necrosis factor-α-induced human vascular smooth muscle proliferation
27. Liposomal formulations of synthetic MUC1 peptides: Effects of encapsulation versus surface display of peptides on immune responses
28. INK4A fusion protein human diploid fibroblasts
29. In vivo protein transduction: Delivery of a biologically active protein into the mouse
30. An evaluation of receptor-mediated gene transfer using synthetic DNA-ligand complexes
31. Delivery of macro-molecules into living cells: A method that exploits folate receptor endocytosis
32. Atomic force microscopic analysis of the infuence of the molecular weight of poly-L-lysine on the size of polyelectrolyte complexes formed with DNA
33. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: Polyethylenimine
34. Efficient gene transfer into mammalian primary endocrine cells with lipopolyamine-coated DNA
35. Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations
36. Lipofection: A highly efficient, lipid-mediated DNA-transfection procedure
37. Gene transfer with synthetic cationic amphiphiles: Prospects for gene therapy
38. Peptide-mediated gene delivery: Influence of peptide structure on gene expression
39. The influence of endosome-disruptive peptides on gene transfer using synthetic virus-like gene transfer systems
40. Branched cationic peptides for gene delivery: Role of type and number of cationic residues in formation and in vitro activity of DNA polyplexes
41. Transferrin-polycation conjugates as carriers for DNA uptake into cells
42. Glycerol and polylysine synergize in their ability to rupture vesicular membranes: A mechanism for increased transferrin-polylysine-mediated gene transfer
43. Glycerol enhancement of ligand-polylysine/DNA transfection
44. Downregulation of amyloid precursor protein inhibits neurite outgrowth in vitro
45. Downregulation of Cu/Zn superoxide dismutase leads to cell death via the nitric oxide-peroxynitrite pathway
46. High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates
47. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells
48. Brain drug delivery technologies: Novel approaches for transporting therapeutics
49. Enhanced delivery of doxorubicin into the brain via a peptide-vector- mediated strategy: Saturation kinetics and specificity
50. Determination of disulfide bridges in protegrin PG-2, an anti-microbial peptide from porcine leukocytes
51. Change in membrane permeability induced by protegrin 1: Implication of disulfide bridges for pore formation
52. New advances in the transport of doxorubicin through the blood-brain barrier by a peptide vector-mediated strategy
53. Arginine-rich peptides: An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery
54. Characterization of a class of cationic peptides able to facilitate efficient protein transduction in vitro and in vivo
55. Nuclear location signals in polyoma virus large-T
56. A domain of SV40 capsid polypeptide VP1 that specifies migration into the cell nucleus
57. Cell-penetrating SH3 domain blocker peptides inhibit proliferation of primary blast cells from CML patients
58. A chemically synthesized Antennapedia homeo domain binds to a specific DNA sequence
59. Antennapedia homeobox peptide regulates neural morphogenesis
60. α-2,8-Polysialic acid is the neuronal surface receptor of antennapedia homeobox peptide
61. Antennapedia homeobox as a signal for the cellular internalization and nuclear addressing of a small exogenous peptide
62. The efficient and rapid import of a peptide into primary B and T lymphocytes and a lymphoblastoid cell line
63. The structure of the homeodomain and its functional implications
64. Homeodomain-derived peptides. In and out of cells
65. Promoter-specific regulation of gene expression by an exogenously added homedomain that promotes neurite growth
66. The third helix of the Antennapedia homeodomain translocates through biological membranes
67. Cell internalization of the third helix of the Antennapedia homeodomain is receptor-independent
68. The retro-inverso form of a homeobox-derived short peptide is rapidly internalised by cultured neurones: A new basis for an efficient intracellular delivery system
69. Selective inhibition of growth factor-stimulated mitogenesis by a cell-permeable Grb2-binding peptide
70. The CDC42-specific inhibitor derived from ACK-1 blocks v-Ha-Ras-induced transformation
71. Trojan peptides: The penetratin system for intracellular delivery
72. Structure - Activity relationship of truncated and substituted analogues of the intracellular delivery vector Penetratin
73. A new Antennapedia-derived vector for intracellular delivery of exogenous compounds
74. Transcription factor hoxa-5 is taken up by cells in culture and conveyed to their nuclei
75. Efficient intracellular delivery of GFP by homeo-domains of Drosophila Fushi-tarazu and Engrafted proteins
76. The position of the cell penetrating peptide penetratin in SDS micelles determined by NMR
77. Conformational and associative behaviours of the third helix of antennapedia homeodomain in membrane-mimetic environments
78. Interaction of the third helix of Antennapedia homeodomain and a phospholipid monolayer, studied by elliptometry and PM-IRRAS at the air - Water interface
79. Interaction and structure induction of cell-penetrating peptides in the presence of phospholipid vesicles
80. Physicochemical requirements for cellular uptake of pAntp peptide. Role of lipid-binding affinity
81. The Antennapedia peptide penetratin translocates across lipid bilayers - The first direct observation
82. Translocation of the pAntp peptide and Its amphipathic analogue AP-2AL
83. Messenger proteins: Homeoproteins, TAT and others
84. A short region of its homeodomain is necessary for Engrailed nuclear export and secretion
85. Identification of a signal sequence necessary for the unconventional secretion of Engrailed homeoprotein
86. A p21(Waf1/Cip1)carboxyl-terminal peptide exhibited cyclin-dependent kinase-inhibitory activity and cytotoxicity when introduced into human cells
87. Selective killing of transformed cells by cyclin/cyclin-dependent kinase 2 antagonists
88. WAF1-derived peptides linked to an internalization peptide inhibit human cancer cell growth
89. WAF1
90. SSeCKS, a major protein kinase C substrate with tumor suppressor activity, regulates G1/S progression by controlling the expression and cellular compartmentalization of cyclin D
91. Bak BH3 peptides antagonize Bcl-xL function and induce apoptosis through cytochrome c-independent activation of caspases
92. PSM, a mediator of PDGF - BB-, IGF - I-, and insulin-stimulated mitogenesis
93. Inhibition of FGF-stimulated phosphatidylinositol hydrolysis and neutrite out-growth by a cell-membrane premeable phosphopeptide
94. Grb10, a positive, stimulatory signaling adapter in platelet-derived growth factor BB-, insulin-like growth factor I-, and insulin-mediated mitogenesis
95. Apoptosis induced in mammalian cells by small peptides that funcionally antagonize the Rb-regulated E2F transcription factor
96. A Sos-derived peptidimer blocks the Ras signaling pathway by binding both Grb2 SH3 domains and displays antiproliferative activity
97. Characterization of the cyclin-dependent kinase inhibitory domain of the INK4 family as a model for a synthetic tumour suppressor molecule
98. CDKN2/INK4A
99. Conformational and molecular basis for induction of apoptosis by a p53 C-terminal peptide in human cancer cells
100. Rapid induction of apoptosis mediated by peptides that bind initiation factor eIF4E
101. Inhibition of cancer cell growth and c-Myc transcriptional activity by a c-Myc helix 1-type peptide fused to an internalization sequence
102. 3 to focal contacts
103. Hyaluronan-dependent cell migration can be blocked by a CD44 cytoplasmic domain peptide containing a phosphoserine at position 325
104. Introduction of exogenous antigens into the MHC class I processing and presentation pathway by Drosophila antennapedia homeodomain primes cytotoxic T cells in vivo
105. Selective inhibition of NF-κB activation by a peptide that blocks the interaction of NEMO with the IκB kinase complex
106. Protein kinase C-ε is responsible for the protection of preconditioning in rabbit cardiomyocytes
107. Identification of Grb2 as a novel binding partner of tumor necrosis factor (TNF) receptor I
108. The contrasting roles of ICE family proteases and interleuk/n-1-β on apoptosis induced by trophic factor withdrawal and by copper/zinc superoxide dismutase down-regulation
109. Intraneuronal delivery of protein kinase C pseudosubstrate leads to growth cone collapse
110. A peptide nucleic acid (PNA) is more rapidly internalized in cultured neurons when coupled to a retro-inverso delivery peptide. The antisense activity depresses the target mRNA and protein in magnocellular oxytocin neurons
111. Antisense inhibition of P-glycoprotein expression using peptide - Oligonucleotide conjugates
112. Inhibition of telomerase activity by a cell-penetrating peptide nucleic acid construct in human melanoma cells
113. Cell penetrating PNA constructs regulate galanin receptor levels and modify pain transmission in vivo
114. Cellular uptake of the tat protein from human immunodeficiency virus
115. Autonomous functional domains of chemically synthesized human immunodeficiency virus Tat trans-activator protein
116. Effects of the tat basic domain on human immunodeficiency virus type 1 transactivation, using chemically synthesized tat protein and tat peptides
117. Tat-mediated delivery of heterologous proteins into cells
118. Enhanced in vitro tumour cell retention and internalization of antibody derivatized with synthetic peptides
119. Tumor cell retention of antibody Fab fragments is enhanced by attached HIV tat protein-derived peptide
120. Activating region of HIV-1 tat protein: Vacuum UV circular dichroism and energy minimization
121. Structural and functional characterization of human immunodeficiency virus tat protein
122. The HIV-1 Tat nuclear localization sequence confers novel nuclear import properties
123. A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus
124. Analysis of arginine-rich peptides from the HIV Tat protein reveals unusual features of RNA-protein recognition
125. Identification of an Arg-Gly-Asp (RGD) cell adhesion site in human immunodeficiency virus type 1 transactivation protein, tat
126. Endocytosis and targeting of exogenous HIV-1 Tat protein
127. Protein transduction: Unrestricted delivery into all cells?
128. Is EIAV Tat protein a homeodomain?
129. TCR antigen-induced cell death occurs from a late G1 phase cell cycle check point
130. Hypophosphorylation of the retinoblastoma protein (pRb) by cyclin D: Cdk4/6 complexes resul; ts in active pRb
131. 1
132. Killing HIV-infected cells by tranduction with an HIV protease-activated caspase-3 protein
133. Peptide-mediated cellular delivery
134. In vivo protein transduction: Intracellular delivery of biologically active proteins, compounds and DNA
135. Kip1 induces cell migration
136. Nuclear translocation of an exogenous fusion protein containing HIV Tat requires unfolding
137. The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: Peptoid molecular transporters
138. Structure - Activity relationship study of the plasma membrane translocating potential of a short peptide from HIV-1 Tat protein
139. Polyarginine enters cells more efficiently than other polycationic homopolymers
140. High affinity and specific binding of HIV-1 TAR RNA by a Tat-derived oligourea
141. An inhibitor of the Tat/TAR RNA interaction that effectively suppresses HIV-1 replication
142. Entry of the toxic proteins abrin, modeccin, ricin, and diphtheria toxin into cells. II. Effect of pH, metabolic inhibitors, and ionophores and evidence for toxin penetration from endocytotic vesicles
143. Conjugation of arginine oligomers to cyclosporin A facilitates topical delivery and inhibition of inflammation
144. Novel cell permeable motif derived from the PreS2-domain of hepatitis-B virus surface antigens
145. Studies on the attachment and penetration of hepatitis B virus
146. Protease-induced infectivity of hepatitis B virus for a human hepato-blastoma cell line
147. Intercellular trafficking and protein delivery by a herpesvirus structural protein
148. Phosphorylation of the herpes simplex virus type 1 tegument protein VP22
149. Intercellular trafficking of VP22-GFP fusion proteins is not observed in cultured mammalian cells
150. Intercellular spread of GFP-VP22
151. Evaluation of VP22 spread in tissue culture
152. Direct protein transfer to terminally differentiated muscle cells
153. Intercellular trafficking of VP22-GFP fusion proteins
154. Quantification of VP22-GFP spread by direct fluorescence in 15 commonly used cell lines
155. Intercellular delivery of a herpes simplex virus VP22 fusion protein from cells infected with lentiviral vectors
156. Intercellular delivery of thymidine kinase prodrug activating enzyme by the herpes simplex virus protein, VP22
157. Intercellular delivery of functional p53 by the herpesvirus protein VP22
158. Recognition of herpes simplex virus type 2 tegument proteins by CD4 T cells infiltrating human genital herpes lesions
159. Catch VP22: The hitch-hiker's ride to gene therapy?
160. Hydrophobic content and lipid interactions of wild-type and mutant OmpA signal peptides correlate with their in vivo function
161. The role of the N region in signal sequence and signal-anchor function
162. The signal peptide
163. Noninvasive intracellular delivery of functional peptides and proteins
164. The distribution of physical, chemical and conformational properties in signal and nascent peptides
165. Inhibition of nuclear translocation of transcription factor NF-κB by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence
166. 3 by using cell-permeable peptide analogues
167. Design of carrier peptide - Oligonucleotide conjugates with rapid membrane translocation and nuclear localization properties
168. Molecular mechanisms of protein secretion: The role of the signal sequence
169. Sequence requirements for nuclear location of simian virus 40 large-T antigen
170. Conformations of primary amphipathic carrier peptides in membrane mimicking environments
171. Controlling epidermal growth factor (EGF)-stimulated Ras activation in intact cells by a cell-permeable peptide mimicking phosphorylated EGF receptor
172. Dissecting G protein-coupled receptor signaling pathways with membrane-permeable blocking peptides
173. Role of the nuclear localization sequence in fibroblast growth factor-1-stimulated mitogenic pathways
174. Nuclear factor-kappaB inhibitor peptide inhibits spontaneous and interleukin-1β-induced sleep
175. A D-amino acid peptide inhibitor of NF-κB nuclear localization is efficacious in models of inflammatory disease
176. Strong suppression of feeding by a peptide containing both the nuclear localization sequence of fibroblast growth factor-1 and a cell membrane-permeable sequence
177. Genetic engineering of proteins with cell membrane permeability
178. Cellular import of functional peptides to block intracellular signaling
179. Membrane insertion and lateral mobility of synthetic amphiphilic signal peptides in lipid model membrane
180. Peptide - Oligonucleotide phosphorothioate conjugates with membrane translocation and nuclear localization properties
181. Cellular delivery of oligonucleotides by synthetic import peptide carrier
182. Viral and cellular membrane fusion proteins
183. Detection of a fusion peptide sequence in the transmembrane protein of human immuno-deficiency virus
184. Characterization of the fusion domain of the human immunodeficiency virus type 1 envelope glycoprotein gp41
185. Identification and characterization of fusion and processing domains of the human immunodeficiency virus type 2 envelope glycoprotein
186. Mutational analysis of the fusion peptide of the human immunodeficiency virus type 1: Identification of critical glycine residues
187. Target cell-specific determinants of membrane fusion within the human immunodeficiency virus type 1 gp120 third variable region and gp41 amino terminus
188. Induction of anti-HIV neutralizing antibodies by synthetic peptides
189. Interaction of human immuno-deficiency virus (HIV-1) fusion peptides with artificial lipid membranes
190. Phospholipid interactions of synthetic peptides representing the N-terminus of HIV gp41
191. Lipid membrane fusion induced by the human immunodeficiency virus type 1 gp41 N-terminal extremity is determined by its orientation in the lipid bilayer
192. The aminoterminal peptide of HIV-1 glycoprotein 41 interacts with human erythrocyte membranes: Peptide conformation, orientation and aggregation
193. The nuclear membrane
194. Solid-phase synthesis and cellular localization of a C- and/or N-terminal labeled peptide
195. A new peptide vector for efficient delivery of oligonucleotides into mammalian cells
196. A new potent HIV-1 reverse transcriptase inhibitor. A synthetic peptide derived from the interface subunit domains
197. Membrane destabilization by N-terminal peptides of viral envelope proteins
198. Structure of influenza haemagglutinin at the pH of membrane fusion
199. pH-dependent membrane fusion activity of a synthetic twenty amino acid peptide with the same sequence as that of the hydrophobic segment of influenza virus hemagglutinin
200. Pharmaceutical perspectives of nonviral gene therapy
201. Cytosolic and nuclear delivery of oligonucleotides mediated by an amphiphilic anionic peptide
202. Improved biological activity of antisense oligonucleotides conjugated to a fusogenic peptide
203. pH-dependent membrane fusion and vesiculation of phospholipid large unimellar vesicles induced by amphiphilic anionic and cationic peptides
204. Membrane permeabilization and efficient gene transfer by a peptide containing several histidines
205. Synthetic DNA-compacting peptides derived from human sequence enhance cationic lipid-mediated gene transfer in vitro and in vivo
206. Sequence-specific inhibition of human immunodeficiency virus (HIV) reverse transcription by antisense oligonucleotides: Comparative study in cell-free assays and in HIV-infected cells
207. A novel DNA-peptide complex for efficient gene transfer and expression in mammalian cells
208. Influence oflipophilic groups in cationic alpha-helical peptides on their abilities to bind with DNA and deliver genes into cells
209. Interaction of peptide fragment 828-848 of the envelope glycoprotein of human immuno-deficiency virus type 1 with lipid bilayers
210. Intracellular routing and inhibitory activity of oligonucleopeptides containing a KDEL motif
211. Penetration and intracellular routing of nucleus-directed peptide-based shuttles (loligomers) in eukaryotic cells
212. The pH-dependent bilayer destabilization by an amphipathic peptide
213. Design, synthesis, and characterization of a cationic peptide that binds to nucleic acids and permeabilizes bilayers
214. Cellular uptake of an α-helical amphipathic model peptide with the potential to deliver polar compounds into the cell interior nonendocytically
215. Structural requirements for cellular uptake of α-helical amphipathic peptides
216. Chain length of cationic alpha-helical peptide sufficient for gene delivery into cells
217. A serum-resistant cytofectin for cellular delivery of antisense oligodeoxynucleotides and plasmid DNA
218. Antibody to nuclear ribonucleoprotein penetrates live human mononuclear cells through Fc receptors
219. A subgroup of murine monoclonal anti-deoxyribonucleic acid antibodies traverse the cytoplasm and enter the nucleus in a time-and temperature- dependent manner
220. Mechanisms of cellular penetration and nuclear localization of an anti-double strand DNA autoantibody
221. Polyreactive anti-DNA monoclonal antibodies and a derived peptide as vectors for the intracytoplasmic and intranuclear translocation of macromolecules
222. Mimotopes of polyreactive anti-DNA antibodies identified using phage-display peptide libraries
223. Efficient gene delivery by a peptide derived from a monoclonal anti-DNA antibody
224. Cell penetration by transportan
225. Galanin-based peptides, galparan and transportan, with receptor-dependent and independent activities
226. Translocation properties of novel cell penetrating transportan and penetratin analogues
227. Deletion analogues of transportan
228. Cellular uptake and spread of the cell-permeable peptide penetratin in adult rat brain
229. Synthetic protein transduction domains: Enhanced transduction potential in vitro and in vivo
230. Preparation of disulfide-bonded polypeptide heterodimers by titration of thio-activated peptides with thiol-containing peptides
231. Synthesis and membrane permeability of PNA-peptide conjugates
232. Preparation of functionally active cell-permeable peptides by single-step ligation of two peptide modules
233. A general method for the synthesis of 3′-sulfhydryl and phosphate group containing oligonucleotides
234. Efficient methods for attachment of thiol specific probes to the 3′-ends of synthetic oligodeoxyribonucleotides
235. Synthesis of modified building blocks containing amino or thiol moieties: Application of modified oligodeoxynucleotides
236. Chemical synthesis of oligonucleotides contining a free sulphydryl group and subsequent attachment of thiol specific probes
237. A simple method for the introduction of thiol group at 5′-termini of oligodeoxynucleotides
238. The synthesis of protected 5′-mercapto-2′, 5′-dideoxynucleo-side-3′ - O-phosphoramidites; uses of 5′-mercapto-oligodeoxy-reibonucleotides
239. Selective coupling of a highly basic peptide to an oligonucleotide
240. Preparation of Boc-[S - (3-nitro-2-pyridinesulfenyl)]-cysteine and its use for unsymmetrical disulfide bond formation
241. Activation parameters for thiolate-disulfide interchange reactions in aqueous solution
242. New procedures for preparation and isolation of conjugates of proteins and a synthetic copolymer of D-amino acids and immunochemical characterization of such conjugates
243. Routine preparation of thiol oligonucleotides: Application to the synthesis of oligonucleotide - Peptide hybrids
244. Synthesis of defined peptide - Oligonucleotide hybrids contining a nuclear transport signal sequence
245. α-Fmoc-cysteine(S-thiobutyl) derivatized oligodeoxy-nucleotides for the preparation of oligodeoxynucleotide - Peptide hybrid molecules
246. Preparation of oligonucleotide - Peptide conjugates
247. Synthesis and hybridization analysis of a small library of peptide - Oligonucleotide conjugates
248. Disulfide linkage to polyacrylic resin for automated Fmoc peptide synthesis. Immunochemical applications of peptide resins and mercaptoamide peptides
249. α-(bromoacetyl)-peptides
250. The role of solid-phase fragment condensation (SPFC) in peptide synthesis
251. Studies towards the synthesis of peptide - Oligonucleotide conjugates
252. A convenient synthesis of 5′-amino-5′-deoxythymidine and preparation of peptide-DNA hybrids
253. The solid-phase synthesis of oligonucleotides containing a 3′-peptide moiety
254. Solid phase synthesis of directly linked peptide-oligodeocynucleotide hybrids using standard synthesis protocols
255. Solid-phase synthesis of a D-peptide-phosphorothioate oligodeoxynucleotide conjugate from two arms of a poly(ethylene glycol)-polystyrene support
256. A new solidphase synthesis of oligonucleotides 3′-conjugates with peptides
257. Synthesis of proteins by native chemical ligation
258. Efficient conjugation ofpeptides to oligonucleotides by "native ligation"
259. Synthesis of an RNA-peptide conjugate by orthogonal ligation
260. Synthesis of a 39-peptide and 25-peptide by thiol capture ligations: Observation of a 40-fold rate acceleration of the intramolecular O, N-acyltransfer reaction between peptide fragments bearing only cysteine protective groups
261. Template-directed ligation of peptides to oligonucleotides
262. Fluorescence studies of the accessibility of the 3′ ends of the ribosomal RNAs in Escherichia coli ribosomes and subunits
263. Localization of 3′ ends of 5S and 23S rRNAs in reconstituted subunits of Escherichia coli ribosomes
264. Biotin-labeled oligonucleotides: Enzymatic synthesis and use of hybridization probes
265. Rapid and sensitive colorimetric method for visualizing biotinlabeled DNA probes hybridized to DNA or RNA immobilized on nitrocellulose: Bio-blots
266. Phosphitylation of primary carboxamides. Synthesis of peptide - Oligonucleotide conjugates with acylphosphoramidate linkages
267. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model
268. Organ targeting in vivo using phage display peptide libraries
269. A nonviral vector system for efficient gene transfer to corneal endothelial cells via membrane integrins
270. Integrin receptor-targeted transfer peptides for efficient delivery of antisense oligodeoxynucleotides
271. Strategies to achieve targeted gene delivery via the receptor-mediated endocytosis pathway